Efficacy and Safety Outcomes with Pembrolizumab (Pembro) Rechallenge for Patients (Pts) with Advanced/Metastatic Urothelial Cancer (UC) Who Responded To First-Course Treatment

No Thumbnail Available

Date

2023

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

URI

http://hdl.handle.net/11727/12119

Collections

Tıp Fakültesi / Faculty of Medicine

Endorsement

Review

Supplemented By

Referenced By